Literature DB >> 23253383

HDAC2 as a new target to improve schizophrenia treatment.

Mitsumasa Kurita, Terrell Holloway, Javier González-Maeso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23253383      PMCID： PMC3552246          DOI： 10.1586/ern.12.141

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  20 in total

1.  Schizophrenia: The making of a troubled mind.

Authors:  David Dobbs
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation.

Authors:  Herbert Y Meltzer; Stefania Bonaccorso; William V Bobo; Yuejin Chen; Karuna Jayathilake
Journal:  J Clin Psychiatry       Date:  2011-07-12       Impact factor: 4.384

3.  Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

Authors:  Miguel Fribourg; José L Moreno; Terrell Holloway; Davide Provasi; Lia Baki; Rahul Mahajan; Gyu Park; Scott K Adney; Candice Hatcher; José M Eltit; Jeffrey D Ruta; Laura Albizu; Zheng Li; Adrienne Umali; Jihyun Shim; Alexandre Fabiato; Alexander D MacKerell; Vladimir Brezina; Stuart C Sealfon; Marta Filizola; Javier González-Maeso; Diomedes E Logothetis
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

4.  Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.

Authors:  Daniel E Casey; David G Daniel; Carol Tamminga; John M Kane; Tram Tran-Johnson; Patricia Wozniak; Walid Abi-Saab; Jeff Baker; Laura Redden; Nicholas Greco; Mario Saltarelli
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

5.  Identification of a serotonin/glutamate receptor complex implicated in psychosis.

Authors:  Javier González-Maeso; Rosalind L Ang; Tony Yuen; Pokman Chan; Noelia V Weisstaub; Juan F López-Giménez; Mingming Zhou; Yuuya Okawa; Luis F Callado; Graeme Milligan; Jay A Gingrich; Marta Filizola; J Javier Meana; Stuart C Sealfon
Journal:  Nature       Date:  2008-02-24       Impact factor: 49.962

6.  Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Hiroyoshi Takeuchi; Shinichiro Nakajima; Kensuke Nomura; Akira Tanabe; Gohei Yagi; Koichiro Watanabe; Haruo Kashima
Journal:  Hum Psychopharmacol       Date:  2009-12       Impact factor: 1.672

Review 7.  Group II metabotropic glutamate receptors and schizophrenia.

Authors:  José L Moreno; Stuart C Sealfon; Javier González-Maeso
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

Review 8.  Serotonin research: contributions to understanding psychoses.

Authors:  Mark A Geyer; Franz X Vollenweider
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

Review 9.  Decoding the epigenetic language of neuronal plasticity.

Authors:  Emiliana Borrelli; Eric J Nestler; C David Allis; Paolo Sassone-Corsi
Journal:  Neuron       Date:  2008-12-26       Impact factor: 17.173

10.  Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.

Authors:  E Dong; M Nelson; D R Grayson; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205
View more
  6 in total

1.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

2.  HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.

Authors:  Mario de la Fuente Revenga; Daisuke Ibi; Justin M Saunders; Travis Cuddy; Maryum K Ijaz; Rudy Toneatti; Mitsumasa Kurita; Terrell Holloway; Li Shen; Jeremy Seto; Mikhail G Dozmorov; Javier González-Maeso
Journal:  Neuroscience       Date:  2018-07-17       Impact factor: 3.590

Review 3.  Epigenetic signaling in schizophrenia.

Authors:  Daisuke Ibi; Javier González-Maeso
Journal:  Cell Signal       Date:  2015-06-26       Impact factor: 4.315

Review 4.  Epigenetic Mechanisms of Serotonin Signaling.

Authors:  Terrell Holloway; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2015-03-10       Impact factor: 4.418

Review 5.  NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.

Authors:  Melissa A Snyder; Wen-Jun Gao
Journal:  Schizophr Res       Date:  2019-04-09       Impact factor: 4.939

6.  Comprehensive DNA Methylation Analysis of Human Neuroblastoma Cells Treated With Haloperidol and Risperidone.

Authors:  Jianbin Du; Yutaka Nakachi; Tomoki Kiyono; Shinya Fujii; Kiyoto Kasai; Miki Bundo; Kazuya Iwamoto
Journal:  Front Mol Neurosci       Date:  2021-12-06       Impact factor: 5.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.